111 related articles for article (PubMed ID: 18217980)
1. Microarray analysis of normal cervix, carcinoma in situ, and invasive cervical cancer: identification of candidate genes in pathogenesis of invasion in cervical cancer.
Song JY; Lee JK; Lee NW; Jung HH; Kim SH; Lee KW
Int J Gynecol Cancer; 2008; 18(5):1051-9. PubMed ID: 18217980
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide gene expression profiling of cervical cancer in Hong Kong women by oligonucleotide microarray.
Wong YF; Cheung TH; Tsao GS; Lo KW; Yim SF; Wang VW; Heung MM; Chan SC; Chan LK; Ho TW; Wong KW; Li C; Guo Y; Chung TK; Smith DI
Int J Cancer; 2006 May; 118(10):2461-9. PubMed ID: 16353136
[TBL] [Abstract][Full Text] [Related]
3. Molecular characterization of adenocarcinoma and squamous carcinoma of the uterine cervix using microarray analysis of gene expression.
Chao A; Wang TH; Lee YS; Hsueh S; Chao AS; Chang TC; Kung WH; Huang SL; Chao FY; Wei ML; Lai CH
Int J Cancer; 2006 Jul; 119(1):91-8. PubMed ID: 16450401
[TBL] [Abstract][Full Text] [Related]
4. Identification and characterization of genes involved in the carcinogenesis of human squamous cell cervical carcinoma.
Cheng Q; Lau WM; Tay SK; Chew SH; Ho TH; Hui KM
Int J Cancer; 2002 Mar; 98(3):419-26. PubMed ID: 11920594
[TBL] [Abstract][Full Text] [Related]
5. Progression-specific genes identified by expression profiling of matched ductal carcinomas in situ and invasive breast tumors, combining laser capture microdissection and oligonucleotide microarray analysis.
Schuetz CS; Bonin M; Clare SE; Nieselt K; Sotlar K; Walter M; Fehm T; Solomayer E; Riess O; Wallwiener D; Kurek R; Neubauer HJ
Cancer Res; 2006 May; 66(10):5278-86. PubMed ID: 16707453
[TBL] [Abstract][Full Text] [Related]
6. Gene profiles between non-invasive and invasive colon cancer using laser microdissection and polypeptide analysis.
Zhu JS; Guo H; Song MQ; Chen GQ; Sun Q; Zhang Q
World J Gastroenterol; 2008 Oct; 14(38):5887-92. PubMed ID: 18855989
[TBL] [Abstract][Full Text] [Related]
7. Variation in apoptotic gene expression in cervical cancer through oligonucleotide microarray profiling.
Zhu MY; Chen F; Niyazi M; Sui S; Gao DM
J Low Genit Tract Dis; 2015 Jan; 19(1):46-54. PubMed ID: 24914885
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of insulin-like growth factor binding protein-5 (IGFBP-5): novel marker for cervical carcinogenesis.
Miyatake T; Ueda Y; Nakashima R; Yoshino K; Kimura T; Murata T; Nomura T; Fujita M; Buzard GS; Enomoto T
Int J Cancer; 2007 May; 120(10):2068-77. PubMed ID: 17290407
[TBL] [Abstract][Full Text] [Related]
9. Clinical value of thymidine kinase in patients with cervical carcinoma.
Fujiwaki R; Hata K; Moriyama M; Iwanari O; Katabuchi H; Okamura H; Miyazaki K
Oncology; 2001; 61(1):47-54. PubMed ID: 11474248
[TBL] [Abstract][Full Text] [Related]
10. Identification of NDRG1-regulated genes associated with invasive potential in cervical and ovarian cancer cells.
Zhao G; Chen J; Deng Y; Gao F; Zhu J; Feng Z; Lv X; Zhao Z
Biochem Biophys Res Commun; 2011 Apr; 408(1):154-9. PubMed ID: 21463610
[TBL] [Abstract][Full Text] [Related]
11. Osteopontin expression correlates with invasiveness in cervical cancer.
Song JY; Lee JK; Lee NW; Yeom BW; Kim SH; Lee KW
Aust N Z J Obstet Gynaecol; 2009 Aug; 49(4):434-8. PubMed ID: 19694703
[TBL] [Abstract][Full Text] [Related]
12. The presence of high-risk HPV combined with specific p53 and p16INK4a expression patterns points to high-risk HPV as the main causative agent for adenocarcinoma in situ and adenocarcinoma of the cervix.
Zielinski GD; Snijders PJ; Rozendaal L; Daalmeijer NF; Risse EK; Voorhorst FJ; Jiwa NM; van der Linden HC; de Schipper FA; Runsink AP; Meijer CJ
J Pathol; 2003 Dec; 201(4):535-43. PubMed ID: 14648656
[TBL] [Abstract][Full Text] [Related]
13. Repression of miR-126 and upregulation of adrenomedullin in the stromal endothelium by cancer-stromal cross talks confers angiogenesis of cervical cancer.
Huang TH; Chu TY
Oncogene; 2014 Jul; 33(28):3636-47. PubMed ID: 24037526
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-138 is a potential biomarker and tumor suppressor in human cervical carcinoma by reversely correlated with TCF3 gene.
Li H; Sheng Y; Zhang Y; Gao N; Deng X; Sheng X
Gynecol Oncol; 2017 Jun; 145(3):569-576. PubMed ID: 28385388
[TBL] [Abstract][Full Text] [Related]
15. Systematic gene microarray analysis of the lncRNA expression profiles in human uterine cervix carcinoma.
Chen J; Fu Z; Ji C; Gu P; Xu P; Yu N; Kan Y; Wu X; Shen R; Shen Y
Biomed Pharmacother; 2015 May; 72():83-90. PubMed ID: 26054679
[TBL] [Abstract][Full Text] [Related]
16. The expression of MAGE and GAGE genes in uterine cervical carcinoma of Korea by RT-PCR with common primers.
Chang HK; Park J; Kim W; Kim K; Lee M; Park U; Choi B
Gynecol Oncol; 2005 May; 97(2):342-7. PubMed ID: 15863128
[TBL] [Abstract][Full Text] [Related]
17. [Global expression analysis in uterine cervical cancer: metabolic pathways and altered genes].
Vázquez-Ortíz G; Piña-Sanchez P; Hidalgo A; Lazos M; Moreno J; Alvarado I; Cruz F; Hernández DM; Pérez-Plascencia C; Salcedo M
Rev Invest Clin; 2005; 57(3):434-41. PubMed ID: 16187704
[TBL] [Abstract][Full Text] [Related]
18. Differential gene expression in cervical cancer cell lines before and after ionizing radiation.
Liu SS; Cheung AN; Ngan HY
Int J Oncol; 2003 May; 22(5):1091-9. PubMed ID: 12684676
[TBL] [Abstract][Full Text] [Related]
19. Analysis of clonality by X chromosome inactivation in uterine cervix cancer.
Ko HM; Choi C; Park CS; Juhng SW
J Korean Med Sci; 1997 Aug; 12(4):322-6. PubMed ID: 9288632
[TBL] [Abstract][Full Text] [Related]
20. Expression profiling of cervical cancers in Indian women at different stages to identify gene signatures during progression of the disease.
Thomas A; Mahantshetty U; Kannan S; Deodhar K; Shrivastava SK; Kumar-Sinha C; Mulherkar R
Cancer Med; 2013 Dec; 2(6):836-48. PubMed ID: 24403257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
